help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-113-3-929
Endocrinology Vol. 113, No. 3 929-938
Copyright © 1983 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PFEIFFER, A.
Right arrow Articles by KOPIN, L J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PFEIFFER, A.
Right arrow Articles by KOPIN, L J.

{alpha}-Receptors Mediate Opioid Cardiovascular Effects at Anterior Hypothalamic Sites through Sympatho- Adrenomedullary and Parasympathetic Pathways*

A. PFEIFFER{dagger}, G. FEUERSTEIN, R. L. ZERBE, A. I. FADEN and L J. KOPIN

National Institute of Mental Health, National Institutes of Health Bethesda, Maryland 20205
Laboratory of Clinical Science, Department of Human Services, National Institutes of Health Bethesda, Maryland 20205
Neurobiology Research Unit, Uniformed Services University of the Health Sciences Bethesda, Maryland 20814

Address correspondence and requests for reprints to: Dr. Giora Feuerstein, Neurobiology Research Unit, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, Maryland 20814.

Abstract

Intracerebroventricular injections of selective opioid agonists were used to investigate the role of opiate receptor subtypes in cardiovascular function in awake rats. The µ-agonist (D-Ala2,MePhe4,Gly5-ol)enkephalin (1 nmol) caused a prolonged increase in blood pressure and an initial decrease followed by a delayed increase in heart rate. These effects were antagonized by the selective µ-antagonist β-funaltrexamine. A selective 5-agonist (dimeric tetrapeptide enkephalin) was devoid of cardiovascular effects at 10 nmol, whereas a benzomorphan {kappa}-agonist MRZ caused a pressor response which was not antagonized by β-funaltrexamine.

The mechanisms by which opioids elicit cardiovascular effects were analyzed in detail by using microinjections into the anterior hypothalamic area. Low doses of enkephalin produced increases in heart rate and blood pressure. Associated elevations of plasma norepinephrine and epinephrine, but not vasopressin, suggested a stimulation of sympatho-adrenomedullary pathways. Higher doses caused increases in blood pressure but decreases in heart rate. Peripheral vagal blockade with atropine methyl nitrate caused a large sudden rise in heart rate, indicating that an increased vagal outflow counteracted the sympathetic activation. Adrenal demedullated rats displayed no tachycardia after anterior hypothalamic injection of low doses of enkephalin, whereas high dose caused pronounced bradycardia. Additional treatment of demedullated rats with the sympathetic blocker bretylium led to severe hypotension in addition to bradycardia. These data provide evidence that {alpha}-opiate receptors primarily mediate cardiovascular effects of opiates in awake rats. At low doses, a sympathetic adrenomedullary activation occurs, whereas higher doses additionally activate parasympathetic efferents, both possibly from anterior hypothalamic sites. (Endocrinology 113:929, 1983)

Footnotes

* This work was supported by the Uniformed Services University of the Health Sciences Protocol RO-9201. The opinions or assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense or the Uniformed Services University of the Health Sciences. The experiments reported herein were conducted according to the principles set forth in the "Guide for the Care and Use of Laboratory Animals," Institute of Laboratory Animal Resources, National Research Council DHEW Pub. [NIH] 78-23.

{dagger} Supported the Deutsche Forschungsgemeinschaft.

Received October 21, 1982.




This article has been cited by other articles:


Home page
DiabetesHome page
J.-T. Cheng, I-M. Liu, T.-C. Chi, T.-F. Tzeng, F.-H. Lu, and C. J. Chang
Plasma Glucose-Lowering Effect of Tramadol in Streptozotocin-Induced Diabetic Rats
Diabetes, December 1, 2001; 50(12): 2815 - 2821.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Shirasaka, T. Kunitake, K. Kato, M. Takasaki, and H. Kannan
Nociceptin modulates renal sympathetic nerve activity through a central action in conscious rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1025 - R1032.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Guasti, P. Grimoldi, A. Diolisi, M. R. Petrozzino, G. Gaudio, A. M. Grandi, M. G. Rossi, and A. Venco
Treatment With Enalapril Modifies the Pain Perception Pattern in Hypertensive Patients
Hypertension, May 1, 1998; 31(5): 1146 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Bachelard, M. Pître, and A. Lessard
Mechanisms of the Regional Hemodynamic Effects of a µ-Opioid Receptor Agonist Microinjected into the Hypothalamic Paraventricular Nuclei of Conscious Unrestrained Rats
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 460 - 470.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society